1279 - Real World Treatment Experience of Treatment-Naïve People with HIV who Initiated Treatment with Single Tablet Dolutegravir/Lamivudine in a Test and Treat setting in the US.

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

JK

Jennifer Kuretski, DNP, APRN, NP-C, AAHIVS

Nurse Practitioner
Midway Specialty Care Center
West Palm Beach, Florida, United States
CD

Cindy Donovan, PharmD

ViiV Healthcare
Research Triangle Park, North Carolina, United States
GH

Gavin Harper, BA

Adelphi Real World
Bollington, England, United Kingdom
DM

Deanna Merrill, PharmD, MBA, AAHIVP

Medical Affairs Scientific Director, Research
ViiV Healthcare
Research Triangle Park, North Carolina, United States
KM

Katie L. Mycock, MChem

Associate Manager, Observational Research
Adelphi Real World
Bollington, England, United Kingdom
Alan Oglesby, MPH

Sr. Director
ViiV Healthcare
Research Triangle Park, North Carolina, United States
Aimee Metzner, PharmD, AAHIVP

US Health Outcomes Director
ViiV Healthcare
Durham, North Carolina, United States

Jimena Patarroyo, PharmD, AAHIVP

Senior Medical Science Liaison
ViiV Healthcare
Research Triangle Park, North Carolina, United States